Grace Therapeutics GRCE
NASDAQ GRCE
$2.01 +0.03 (+1.55%)
As of: Oct 21, 2026 · 3:09 PM EDT

Grace Therapeutics (GRCE) Other Operating Expenses (2022 - 2026)

Updated

Grace Therapeutics (GRCE) recorded Other Operating Expenses of $898,000 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 9.1% from $988,000 a year earlier and down 42.0% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Other Operating Expenses (2022 - 2026) Analysis & Trends

On a TTM basis, Grace Therapeutics' Other Operating Expenses came in at $4.42 million as of Jun 30, 2026, up 38.1% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $4.51 million, up 21.7% from FY2025.

  • Annual Other Operating Expenses has a three-year compound annual growth rate of 666.9% (FY2023 to FY2026).
  • Across earlier fiscal years, Other Operating Expenses came in at $3.71 million in FY2025 (+6.7%), $3.48 million in FY2024 and $10,000 in FY2023.
  • Quarterly Other Operating Expenses has ranged from $4,000 in fiscal Q2 2023 to $1.55 million in fiscal Q4 2026 over the past five years.
  • On a year-over-year basis, Other Operating Expenses rose in three of the last five quarters, with growth averaging 32.6%.
  • Per Business Quant, the preceding three fiscal quarters came in at $1.55 million (Q4 2026), $870,000 (Q3 2026) and $1.1 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.48 Bn 1,106.07 Bn 19.71 Bn
2 Johnson & Johnson 618.81 Bn 537.34 Bn 17.26 Bn
3 AbbVie 502.02 Bn 475.14 Bn 12.70 Bn
4 Merck 368.25 Bn 322.63 Bn 12.21 Bn
5 Novartis Ag 297.87 Bn 261.86 Bn 11.24 Bn
6 Astrazeneca 260.90 Bn 234.58 Bn 12.86 Bn
7 Amgen 236.67 Bn 192.07 Bn 7.24 Bn
8 Gilead Sciences 191.16 Bn 165.36 Bn 6.22 Bn
9 Pfizer 169.69 Bn 116.34 Bn 10.94 Bn
10 Grace Therapeutics 34.71 Mn -31.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 384,000.00
Mar 31, 2026 534,000.00
Dec 31, 2025 595,000.00
Sep 30, 2025 380,000.00
Jun 30, 2025 552,000.00
Mar 31, 2025 398,000.00
Dec 31, 2024 349,000.00
Sep 30, 2024 267,000.00
Jun 30, 2024 224,000.00
Sep 30, 2022 4,000.00
Jun 30, 2022 6,000.00
API Access

Grace Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=GRCE&period=max&api_key=YOUR_API_KEY